
MHRA clears the Covid jab for 12-15 year olds
MHRA clears the Covid jab for 12-15 year olds
CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses
Company unifies its patient support services
A global push for getting corporations to commit to electric vehicles catches hold among big pharma companies
Vaccine maker will use CDMO’s South Korean facilities to support additional Covid doses
Big techs such as Amazon and Uber could help drive machinery surge
Company's container maintains a -70°C temperature for at least 240 hours
Pharma and nutraceuticals collaborate, as deal introduces logistics program to Bonne Santé Group
First-hand insight on how pharma manufacturers, navigating the challenges of a pandemic, are tapping data analytics for increased visibility into supply chain operations
Portrix acquisition strengthens company’s supply chain presence
Marks the first US Covid vaccine authorized for this age group
Drug shortages are inevitable—being caught off guard isn’t. The best ways distributors can use and position data to drive today’s inventory solutions
Nationally and internationally, the logistics service providers for life sciences see a new vista
Luxembourg-based manufacturer attributes increase in demand to the current pandemic
CDMO giant invests nearly $1 billion in Switzerland and New Hampshire sites
Purchase of technology-powered CRO grows Aixial's offerings in clinical operations and product development
Report shows that air cargo demand is at a record high
“Lab to Life” partnership aims to better analyze clinical, real-world and commercial data
Includes initial 34 million doses to be delivered in quarter four
After extensive testing of packaging, American Airlines Cargo expands pharma service capabilities
Company also says that drug substance manufacturing can double at its facilities
Deal gives avenue for investment firm to expand pharma distribution reach
As India Covid cases continue to spike, biotech company will provide resources to help boost local manufacturing
Partnership will begin with tackling Friedreich’s ataxia, then extend to other gene transfer therapies
Platform partnerships aim to unlock new ways for pharma to engage with HCPs and patients